MISSOURI MPJE EVALUATION EXAM 2026 QUESTIONS
AND SOLUTIONS GRADED A+
✔✔How long after a complaint is filed will the AHC determine whether the alleged
activities of the
wholesale drug distributor or pharmacy distributor appear to constitute a clear and
present danger to the public
health and safety which justify that the wholesale drug distributor's or pharmacy
distributor's license be
immediately restricted or suspended? - ✔✔Within 15 days
✔✔How recent must a satisfactory rating be documented for a wholesaler to be exempt
from further inspections? - ✔✔in the past 2 years
✔✔The board may establish an impaired licensee committee, to be designated as
__________to promote the early identification, intervention, treatment, and rehabilitation
of licensees who may be impaired by reasons of illness, substance abuse, or as a result
of any physical or mental condition. - ✔✔the "Well-being
Committee"
✔✔Are the records and proceedings of the Well-being committee which pertain or refer
to a licensee is impaired considered public records or confidential? - ✔✔Confidential -
shall only be subject to discovery or introduction as evidence in any civil, criminal, or
administrative proceedings
✔✔The committee may disclose information relative to an impaired licensee only when:
- ✔✔(1) It is essential to disclose the information to further the intervention, treatment,
or rehabilitation needs
of the impaired licensee and only to those persons or organization with a need to know;
(2) Its release is authorized in writing by the impaired licensee;
(3) The committee is required to make a report to the board; or
(4) The information is subject to a court order
✔✔What is the maximum number of diversion agreements the board will enter into with
any one licensee? - ✔✔two
✔✔The committee shall report to the board the name of any licensee who fails to enter
treatment within
________ following the provider's determination - ✔✔48 hours
✔✔"Ancillary infusion equipment and supplies" - ✔✔equipment and supplies required to
infuse a blood
clotting therapy product into a human vein, including syringes, needles, sterile gauze,
field pads, gloves, alcohol
, swabs, numbing creams, tourniquets, medical tape, sharps or equivalent biohazard
waste containers, and cold
compression packs
✔✔"Assay" - ✔✔the amount of a particular constituent of a mixture or of the biological
or pharmacological potency of a drug
✔✔"Bleeding disorder" - ✔✔a medical condition characterized by a deficiency or
absence of one or more essential blood-clotting components in the human blood,
including all forms of hemophilia, von Willebrand's disease, and other bleeding
disorders that result in uncontrollable bleeding or abnormal blood clotting
✔✔Who helps MO board make rules governing the standard of care for pharmacies
dispensing blood clotting therapies? - ✔✔the medical advisory committees of the patient
groups representing the hemophilia and von
Willebrand diseases, including but not limited to Recommendation 188 of the National
Hemophilia
Foundation's Medical and Scientific Advisory Council
✔✔What are the requirements for a pharmacy to dispense blood clotting therapy
products? - ✔✔Has the ability to obtain and fill a physician prescription as written of all
brands of blood clotting
products approved by the federal Food and Drug Administration in multiple assay
ranges of low, medium, and
high, as applicable, and vial sizes, including products manufactured from human plasma
and those
[35]
manufactured from recombinant technology techniques, provided manufacturer supply
exists and payer
authorization is obtained;
(2) Provides for the shipment of prescribed blood clotting products to the patient within
two business
days or less for established patients and three business days or less for new patients in
nonemergency situations;
(3) Provides established patients with access to blood clotting products within twelve
hours of
notification by the physician of the patient's emergent need for blood clotting products;
(4) Provides all ancillary infusion equipment and supplies necessary for established
patients for
administration of blood clotting products;
(5) Has a pharmacist available twenty-four hours a day, seven days a week, every day
of the year, either
onsite or on call, to fill prescriptions for blood clotting products;
(6) Provides patients who have received blood clotting products with a designated
contact telephone
number for reporting problems with a delivery or product;
AND SOLUTIONS GRADED A+
✔✔How long after a complaint is filed will the AHC determine whether the alleged
activities of the
wholesale drug distributor or pharmacy distributor appear to constitute a clear and
present danger to the public
health and safety which justify that the wholesale drug distributor's or pharmacy
distributor's license be
immediately restricted or suspended? - ✔✔Within 15 days
✔✔How recent must a satisfactory rating be documented for a wholesaler to be exempt
from further inspections? - ✔✔in the past 2 years
✔✔The board may establish an impaired licensee committee, to be designated as
__________to promote the early identification, intervention, treatment, and rehabilitation
of licensees who may be impaired by reasons of illness, substance abuse, or as a result
of any physical or mental condition. - ✔✔the "Well-being
Committee"
✔✔Are the records and proceedings of the Well-being committee which pertain or refer
to a licensee is impaired considered public records or confidential? - ✔✔Confidential -
shall only be subject to discovery or introduction as evidence in any civil, criminal, or
administrative proceedings
✔✔The committee may disclose information relative to an impaired licensee only when:
- ✔✔(1) It is essential to disclose the information to further the intervention, treatment,
or rehabilitation needs
of the impaired licensee and only to those persons or organization with a need to know;
(2) Its release is authorized in writing by the impaired licensee;
(3) The committee is required to make a report to the board; or
(4) The information is subject to a court order
✔✔What is the maximum number of diversion agreements the board will enter into with
any one licensee? - ✔✔two
✔✔The committee shall report to the board the name of any licensee who fails to enter
treatment within
________ following the provider's determination - ✔✔48 hours
✔✔"Ancillary infusion equipment and supplies" - ✔✔equipment and supplies required to
infuse a blood
clotting therapy product into a human vein, including syringes, needles, sterile gauze,
field pads, gloves, alcohol
, swabs, numbing creams, tourniquets, medical tape, sharps or equivalent biohazard
waste containers, and cold
compression packs
✔✔"Assay" - ✔✔the amount of a particular constituent of a mixture or of the biological
or pharmacological potency of a drug
✔✔"Bleeding disorder" - ✔✔a medical condition characterized by a deficiency or
absence of one or more essential blood-clotting components in the human blood,
including all forms of hemophilia, von Willebrand's disease, and other bleeding
disorders that result in uncontrollable bleeding or abnormal blood clotting
✔✔Who helps MO board make rules governing the standard of care for pharmacies
dispensing blood clotting therapies? - ✔✔the medical advisory committees of the patient
groups representing the hemophilia and von
Willebrand diseases, including but not limited to Recommendation 188 of the National
Hemophilia
Foundation's Medical and Scientific Advisory Council
✔✔What are the requirements for a pharmacy to dispense blood clotting therapy
products? - ✔✔Has the ability to obtain and fill a physician prescription as written of all
brands of blood clotting
products approved by the federal Food and Drug Administration in multiple assay
ranges of low, medium, and
high, as applicable, and vial sizes, including products manufactured from human plasma
and those
[35]
manufactured from recombinant technology techniques, provided manufacturer supply
exists and payer
authorization is obtained;
(2) Provides for the shipment of prescribed blood clotting products to the patient within
two business
days or less for established patients and three business days or less for new patients in
nonemergency situations;
(3) Provides established patients with access to blood clotting products within twelve
hours of
notification by the physician of the patient's emergent need for blood clotting products;
(4) Provides all ancillary infusion equipment and supplies necessary for established
patients for
administration of blood clotting products;
(5) Has a pharmacist available twenty-four hours a day, seven days a week, every day
of the year, either
onsite or on call, to fill prescriptions for blood clotting products;
(6) Provides patients who have received blood clotting products with a designated
contact telephone
number for reporting problems with a delivery or product;
